SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-21-136640
Filing Date
2021-11-10
Accepted
2021-11-10 08:06:36
Documents
78
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q ards-20210930x10q.htm   iXBRL 10-Q 1371624
2 EX-31.1 ards-20210930xex31d1.htm EX-31.1 12891
3 EX-31.2 ards-20210930xex31d2.htm EX-31.2 12918
4 EX-32.1 ards-20210930xex32d1.htm EX-32.1 6425
5 EX-32.2 ards-20210930xex32d2.htm EX-32.2 6434
  Complete submission text file 0001104659-21-136640.txt   6495312

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA ards-20210930.xsd EX-101.SCH 61255
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ards-20210930_cal.xml EX-101.CAL 49066
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ards-20210930_def.xml EX-101.DEF 206824
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE ards-20210930_lab.xml EX-101.LAB 500306
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ards-20210930_pre.xml EX-101.PRE 401728
11 EXTRACTED XBRL INSTANCE DOCUMENT ards-20210930x10q_htm.xml XML 964525
Mailing Address 983 UNIVERSITY AVENUE, BLDG. B LOS GATOS CA 95032
Business Address 983 UNIVERSITY AVENUE, BLDG. B LOS GATOS CA 95032 (408) 385-1742
Aridis Pharmaceuticals, Inc. (Filer) CIK: 0001614067 (see all company filings)

IRS No.: 320074500 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38630 | Film No.: 211394513
SIC: 2834 Pharmaceutical Preparations